Literature DB >> 32634088

The histone-like protein AlgP regulon is distinct in mucoid and nonmucoid Pseudomonas aeruginosa and does not include alginate biosynthesis genes.

Ashley R Cross1,2, Erika E Csatary3,1, Vishnu Raghuram1,2, Frances L Diggle1,4,5, Marvin Whiteley4,5,1, William M Wuest3,1, Joanna B Goldberg1,2.   

Abstract

The opportunistic bacterial pathogen Pseudomonas aeruginosa causes acute and chronic infections that are notoriously difficult to treat. In people with cystic fibrosis, P. aeruginosa can cause lifelong lung infections, and isolation of mucoid P. aeruginosa, resulting from the overproduction of alginate, is associated with chronic infection. The histone-like protein AlgP has previously been implicated in the control of alginate gene expression in mucoid strains, but this regulation is unclear. To explore AlgP in further detail, we deleted algP in mucoid strains and demonstrated that the deletion of algP did not result in a nonmucoid phenotype or a decrease in alginate production. We showed that the algP promoter is expressed by both the nonmucoid strain PAO1 and the isogenic mucoid strain PDO300, suggesting that there may be genes that are differentially regulated between these strains. In support of this, using RNA sequencing, we identified a small AlgP regulon that has no significant overlap between PAO1 and PDO300 and established that alginate genes were not differentially regulated by the deletion of algP. Of note, we found that deleting algP in PAO1 increased expression of the nitric oxide operon norCBD and the nitrous oxide reductase genes nosRZ and subsequently promoted growth of PAO1 under anaerobic conditions. Altogether, we have defined a narrow regulon of genes controlled by AlgP and provided evidence that alginate production is not greatly affected by AlgP, countering the long-standing premise in the field.

Entities:  

Keywords:  Pseudomonas; RNA sequencing; alginate; gene regulation; histones

Mesh:

Substances:

Year:  2020        PMID: 32634088      PMCID: PMC7654744          DOI: 10.1099/mic.0.000923

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  37 in total

1.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.

Authors:  J C Boucher; H Yu; M H Mudd; V Deretic
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

3.  Advancing the quorum in Pseudomonas aeruginosa: MvaT and the regulation of N-acylhomoserine lactone production and virulence gene expression.

Authors:  Stephen P Diggle; Klaus Winzer; Andrée Lazdunski; Paul Williams; Miguel Cámara
Journal:  J Bacteriol       Date:  2002-05       Impact factor: 3.490

4.  Biofilm formation in Pseudomonas aeruginosa: fimbrial cup gene clusters are controlled by the transcriptional regulator MvaT.

Authors:  Isabelle Vallet; Stephen P Diggle; Rachael E Stacey; Miguel Cámara; Isabelle Ventre; Stephen Lory; Andrée Lazdunski; Paul Williams; Alain Filloux
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

5.  Pseudomonas aeruginosa AlgB, a two-component response regulator of the NtrC family, is required for algD transcription.

Authors:  D J Wozniak; D E Ohman
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

6.  Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.

Authors:  D W Martin; M J Schurr; M H Mudd; J R Govan; B W Holloway; V Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

7.  Two-pronged survival strategy for the major cystic fibrosis pathogen, Pseudomonas aeruginosa, lacking the capacity to degrade nitric oxide during anaerobic respiration.

Authors:  Sang Sun Yoon; Ahmet C Karabulut; John D Lipscomb; Robert F Hennigan; Sergei V Lymar; Stephanie L Groce; Andrew B Herr; Michael L Howell; Patricia J Kiley; Michael J Schurr; Benjamin Gaston; Kyoung-Hee Choi; Herbert P Schweizer; Daniel J Hassett
Journal:  EMBO J       Date:  2007-07-12       Impact factor: 11.598

Review 8.  CFTR, mucins, and mucus obstruction in cystic fibrosis.

Authors:  Silvia M Kreda; C William Davis; Mary Callaghan Rose
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

9.  Identification of genes in the σ²² regulon of Pseudomonas aeruginosa required for cell envelope homeostasis in either the planktonic or the sessile mode of growth.

Authors:  Lynn F Wood; Dennis E Ohman
Journal:  mBio       Date:  2012-05-15       Impact factor: 7.867

10.  Selective Proteomic Analysis of Antibiotic-Tolerant Cellular Subpopulations in Pseudomonas aeruginosa Biofilms.

Authors:  Brett M Babin; Lydia Atangcho; Mark B van Eldijk; Michael J Sweredoski; Annie Moradian; Sonja Hess; Tim Tolker-Nielsen; Dianne K Newman; David A Tirrell
Journal:  MBio       Date:  2017-10-24       Impact factor: 7.867

View more
  3 in total

1.  The Histone H1-Like Protein AlgP Facilitates Even Spacing of Polyphosphate Granules in Pseudomonas aeruginosa.

Authors:  Ravi Chawla; Steven Klupt; Vadim Patsalo; James R Williamson; Lisa R Racki
Journal:  mBio       Date:  2022-04-18       Impact factor: 7.786

2.  Transcription of the Alginate Operon in Pseudomonas aeruginosa Is Regulated by c-di-GMP.

Authors:  Ziwei Liang; Morten Rybtke; Kasper Nørskov Kragh; Owen Johnson; Muriel Schicketanz; Yong Everett Zhang; Jens Bo Andersen; Tim Tolker-Nielsen
Journal:  Microbiol Spectr       Date:  2022-07-11

3.  Microbial Musings - September 2020.

Authors:  Gavin H Thomas
Journal:  Microbiology (Reading)       Date:  2020-09       Impact factor: 2.777

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.